| |
| |
SPOT ON
|
| |
CONVINCE Study: Early Stop for Commercial Reasons Unethical |
| |
| |
NEW ON THE MARKET
|
| |
Cox-2 Inhibitor Valdecoxib (BEXTRA)
5-Alpha-Reductase Inhibitor Dutasteride (AVODART) in Benign Prostatic Hyperplasia
Chronic Hepatitis B: Adefovir (HEPSERA)
Miglustat (ZAVESCA) as a Remedy for GAUCHER Disease |
| |
| |
REVIEW
|
| |
Treatment of Atopic Dermatitis (II): Further Therapeutic Interventions |
| |
| |
a-t READERS' QUESTIONS AND COMMENTS
|
| |
OMACOR After Myocardial Infarction?
Hip Protectors: Importance of Structured Education Questioned |
| |
| |
IN BRIEF
|
| |
Menopausal Hormone Replacement Without Effect on Quality of Life |
| |
| |
CURRENT ADR NETWORK REPORT
|
| |
Slow-Onset Myopathy Due to Statins
AZUMETOP RETARD Tablets Indigestible |
| |
| |
SIDE EFFECTS
|
 |
Fatalities After Hexavalent Vaccines (HEXAVAC, INFANRIX HEXA)
Homonal Contraceptives and Cervical Cancer
Telithromycin (KETEK): Exacerbation of Myasthenia Gravis |
| |